Abstract:Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease (ILD) with unknown etiology in which gradual fibrotic scarring of the lungs leads to usual interstitial pneumonia (UIP) and, ultimately, to death. IPF affects three million people worldwide, and the only currently available treatments include the antifibrotic drugs nintedanib and pirfenidone, which effectively reduce fibrosis progression are, unfortunately, not effective in curing the disease. In recent years, the paradigm of IPF pathogenesis has shifted from a fibroblast-driven disease to an epithelium-driven disease, wherein, upon recurrent microinjuries, dysfunctional alveolar type II epithelial cells (ATII) are not only unable to sustain physiological lung regeneration but also promote aberrant epithelial–mesenchymal crosstalk. This creates a drift towards fibrosis rather than regeneration. In the context of this review article, we discuss the most relevant mechanisms involved in IPF pathogenesis with a specific focus on the role of dysfunctional ATII cells in promoting disease progression. In particular, we summarize the main causes of ATII cell dysfunction, such as aging, environmental factors, and genetic determinants. Next, we describe the known mechanisms of physiological lung regeneration by drawing a parallel between embryonic lung development and the known pathways involved in ATII-driven alveolar re-epithelization after injury. Finally, we review the most relevant interventional clinical trials performed in the last 20 years with the aim of underlining the urgency of developing new therapies against IPF that are not only aimed at reducing disease progression by hampering ECM deposition but also boost the physiological processes of ATII-driven alveolar regeneration.

Alveolar Epithelial Type 2 Cell Dysfunction in Idiopathic Pulmonary Fibrosis

Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis

Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis

Contributions of alveolar epithelial cell quality control to pulmonary fibrosis

Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF)

Aged alveolar epithelium contributes to inflammaging and reduced stem cell function in the lung

Regenerative capacity of alveolar type 2 cells is proportionally reduced following disease progression in idiopathic pulmonary fibrosis-derived organoid cultures

Senescent AECⅡ and the Implication for Idiopathic Pulmonary Fibrosis Treatment.

Advances in cellular senescence in idiopathic pulmonary fibrosis (Review)

The Alveolar Epithelium and Pulmonary Fibrosis

New Perspectives on the Aberrant Alveolar Repair of Idiopathic Pulmonary Fibrosis

Potential contribution of alveolar epithelial type I cells to pulmonary fibrosis

Idiopathic Pulmonary Fibrosis: A Disorder of Epithelial Cell Dysfunction

[Progress on Correlation Between Cell Senescence and Idiopathic Pulmonary Fibrosis].

Impaired AMPK Control of Alveolar Epithelial Cell Metabolism Promotes Pulmonary Fibrosis

Epithelial-Mesenchymal Transition Contributes to Pulmonary Fibrosis via Aberrant Epithelial/Fibroblastic Cross-Talk

Cellular therapies for idiopathic pulmonary fibrosis: current progress and future prospects

Emerging Roles of Airway Epithelial Cells in Idiopathic Pulmonary Fibrosis